VOLUME 62   2001   SUPPLEMENT 5

Articles

3 Introduction: Comparison of the Bioequivalence of Generic Versus Branded Clozapine. Larry Ereshefsky and Marvin C. Meyer
[PDF]

4 United States Food and Drug Administration Requirements for Approval of Generic Drug Products. Marvin C. Meyer
[Abstract] [PDF]

10 Pharmacokinetic Studies of Antipsychotics in Healthy Volunteers Versus Patients. Neal R. Cutler
[Abstract] [PDF]

14 Clinical Effects of a Randomized Switch of Patients From Clozaril to Generic Clozapine. John C. Kluznik, Nancy H. Walbek, Michael G. Farnsworth, and Kristen Melstrom
[Abstract] [PDF]

18 Branded Versus Generic Clozapine: Bioavailability Comparison and Interchangeability Issues. Y. W. Francis Lam, Larry Ereshefsky, Gregory B. Toney, and Cheryl Gonzales
[Abstract] [PDF]

23 Discussion.
[PDF]

25 Conclusion. Larry Ereshefsky and William M. Glazer
[PDF]

28 Faculty List.
[PDF]